LONDON and NEW YORK - OKYO Pharma Limited (NASDAQ: OKYO), a $36.54 million market cap biotechnology company currently trading at $1.04 per share, engaged in the development of treatments for ocular ...
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...
Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to the pharmaceutical company. The nasal spray can be given to people who haven’t seen improvements ...
The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...
Kentuckians can't get mifepristone to treat miscarriages because of state anti-abortion law, FDA regulation and confusion ...
J&J on Tuesday said the green light makes Spravato the first and only monotherapy for adults with major depressive disorder who have had an inadequate response to at least two oral antidepressants.
Sepsis, the leading cause of death in U.S. hospitals killing about 350,000 people annually, is an extreme response to an ...
It turns out, your protein powder might not be as healthy as you think.A new report from the Clean Label Project revea ...
Made from petroleum and chemically known as erythrosine, red dye No. 3 is a synthetic color additive used to give foods and ...
New Jersey has considered legislation that would ban the sale of smoke free nicotine pouches, following in the footsteps of ...
Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN ...
No. 13 Oregon will seek its first home win over a Top 25 team this season on Saturday afternoon against No. 17 Purdue in a ...